Purdue's Sleep Aid Patents Are Obvious, Judge Rules

March 30, 2015

Law360, New York (March 30, 2015, 3:01 PM ET) -- A New Jersey federal judge on Friday found that Purdue Pharmaceutical Products LP’s three patents for sleep aid Intermezzo are invalid for obviousness, granting a win to Actavis Elizabeth LLC, Novel Laboratories Inc. and others whom Purdue sued over plans to market their own generic versions of the drug.

All Content © 2003‐2015, Portfolio Media, Inc.

Jake M. Holdreith

Partner

Member of Executive Board

Related Publications

First Quarter
ANDA Approvals
GENERICally Speaking Spring 2021
First Quarter
ANDA Litigation Settlements
GENERICally Speaking Spring 2021
First Quarter
Generic Launches
GENERICally Speaking Spring 2021
First Quarter
New ANDA Cases
GENERICally Speaking Spring 2021
March 2, 2021
AstraZeneca AB v. Mylan Pharms. Inc.
GENERICally Speaking Spring 2021
Back to Top